Motif ID: Sox2
Z-value: 3.152

Transcription factors associated with Sox2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Sox2 | ENSMUSG00000074637.4 | Sox2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sox2 | mm10_v2_chr3_+_34649987_34650005 | -0.80 | 3.9e-10 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.3 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
3.8 | 11.3 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
3.2 | 16.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.2 | 9.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
3.2 | 15.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
2.6 | 7.8 | GO:1904347 | intestine smooth muscle contraction(GO:0014827) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) regulation of small intestine smooth muscle contraction(GO:1904347) small intestine smooth muscle contraction(GO:1990770) |
2.6 | 28.2 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.6 | 12.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.4 | 7.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
2.4 | 7.2 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
2.3 | 9.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
2.3 | 2.3 | GO:0061349 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) |
2.2 | 9.0 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
2.2 | 6.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
2.0 | 8.1 | GO:0097393 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
2.0 | 29.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.9 | 7.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.8 | 5.5 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.8 | 26.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.8 | 5.3 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
1.8 | 5.3 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.8 | 5.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.7 | 15.7 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
1.7 | 10.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.7 | 6.8 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
1.7 | 20.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.7 | 13.4 | GO:0061368 | maternal process involved in parturition(GO:0060137) behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.7 | 1.7 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
1.6 | 12.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.5 | 6.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.5 | 6.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.5 | 6.1 | GO:2000110 | protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
1.5 | 11.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.5 | 13.1 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.4 | 2.9 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.4 | 7.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
1.4 | 4.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.3 | 5.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.3 | 4.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.3 | 9.2 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.3 | 2.6 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
1.3 | 6.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
1.3 | 7.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.3 | 3.8 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
1.3 | 3.8 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
1.2 | 7.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.2 | 3.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.2 | 9.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.2 | 4.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.2 | 5.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.1 | 3.4 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 2.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.1 | 3.3 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
1.1 | 5.5 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
1.1 | 4.4 | GO:0061198 | fungiform papilla formation(GO:0061198) |
1.1 | 6.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 3.3 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
1.1 | 4.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.0 | 19.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.0 | 6.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 3.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.0 | 5.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.0 | 4.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.0 | 3.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.0 | 5.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.0 | 4.0 | GO:0021586 | pons maturation(GO:0021586) |
1.0 | 2.0 | GO:0060023 | soft palate development(GO:0060023) |
1.0 | 8.8 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
1.0 | 4.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.0 | 3.9 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
1.0 | 3.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.0 | 3.9 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.0 | 7.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.0 | 3.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
0.9 | 2.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.9 | 3.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 3.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.9 | 5.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.9 | 4.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.9 | 2.8 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.9 | 2.8 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.9 | 2.7 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.9 | 2.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.9 | 3.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.9 | 2.6 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.9 | 4.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.8 | 3.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 5.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.8 | 1.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.8 | 5.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 2.5 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.8 | 5.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.8 | 2.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.8 | 2.5 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.8 | 2.5 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.8 | 0.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.8 | 3.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 3.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.8 | 4.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.8 | 6.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.8 | 1.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.8 | 1.6 | GO:1900133 | renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
0.8 | 7.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 27.6 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.8 | 3.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.8 | 2.3 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.8 | 2.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.8 | 2.3 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.8 | 3.8 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 2.3 | GO:0016598 | protein arginylation(GO:0016598) |
0.7 | 2.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.7 | 2.2 | GO:0072720 | response to sorbitol(GO:0072708) response to dithiothreitol(GO:0072720) |
0.7 | 9.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.7 | 5.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.7 | 2.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 3.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 25.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.7 | 2.9 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.7 | 4.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.7 | 5.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 3.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.7 | 10.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.7 | 4.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.7 | 4.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 4.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.7 | 7.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 8.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.7 | 2.0 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.6 | 0.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.6 | 1.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.6 | 1.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.6 | 1.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.6 | 7.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 1.9 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.6 | 1.9 | GO:0021972 | corticospinal neuron axon guidance(GO:0021966) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.6 | 3.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
0.6 | 1.9 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.6 | 1.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.6 | 1.9 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.6 | 2.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.6 | 2.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 4.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 3.6 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 10.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 1.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.6 | 6.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.6 | 8.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.6 | 2.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 2.3 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.6 | 4.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.6 | 23.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 1.7 | GO:0032570 | response to progesterone(GO:0032570) |
0.6 | 6.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.6 | 2.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.6 | 4.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 2.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 9.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.6 | 1.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.6 | 2.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 0.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 4.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 2.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.5 | 9.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.5 | 2.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 3.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.5 | 3.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 1.5 | GO:1904207 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.5 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 7.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.5 | 1.5 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.5 | 7.8 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 3.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 1.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.5 | 12.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.5 | 1.4 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.5 | 3.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 4.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 1.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 1.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.4 | 0.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 5.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.4 | 2.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 1.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.4 | 0.9 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.4 | 2.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 3.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 1.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.4 | 0.4 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.4 | 2.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.4 | 3.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 3.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 4.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 4.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 1.2 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.4 | 0.8 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.4 | 1.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 6.6 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.4 | 3.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 1.5 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 4.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.4 | 1.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 0.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 3.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 3.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 1.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.4 | 3.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 4.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.4 | 16.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.4 | 3.6 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 3.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 1.8 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.3 | 1.4 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.3 | 1.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 7.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 0.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 1.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 6.6 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.3 | 3.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 4.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 3.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.3 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.3 | 1.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.3 | 1.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.9 | GO:1901228 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) ureteric bud formation(GO:0060676) regulation of osteoclast proliferation(GO:0090289) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) negative regulation of bone development(GO:1903011) |
0.3 | 1.5 | GO:0023021 | termination of signal transduction(GO:0023021) termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.3 | 2.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 4.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 3.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.3 | 0.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.3 | 0.8 | GO:0090646 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
0.3 | 3.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 3.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 2.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 2.4 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.3 | 2.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 1.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 3.7 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.3 | 3.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 6.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 1.6 | GO:0097324 | melanocyte migration(GO:0097324) |
0.3 | 3.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 1.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 0.8 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.5 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 1.2 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.2 | 6.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 4.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 1.5 | GO:1903961 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
0.2 | 1.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 3.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 1.0 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.2 | 0.7 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.2 | 2.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 2.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 1.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 1.4 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.2 | 3.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 3.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 1.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 3.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 2.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 1.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 15.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 1.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.9 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.2 | 3.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 1.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 2.2 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 4.0 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.2 | 0.9 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
0.2 | 3.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 5.7 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 1.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 17.2 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 3.8 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.2 | 4.5 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 33.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.2 | 2.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 2.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 2.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 1.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.8 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.2 | 5.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 12.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 7.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 2.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 3.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 2.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 1.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 5.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 1.8 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.2 | 9.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.2 | 4.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 2.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.9 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 2.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 3.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 5.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 2.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 6.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 3.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 1.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.5 | GO:0044861 | protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
0.2 | 1.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 2.7 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.2 | 0.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 2.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 1.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 2.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 2.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.2 | 1.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 3.0 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.2 | 1.8 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.2 | 1.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 1.2 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 1.5 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 2.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.2 | 1.1 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.2 | 1.9 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 | 0.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 1.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 3.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 3.1 | GO:0060384 | innervation(GO:0060384) |
0.1 | 4.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 1.9 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 3.8 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.1 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 1.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 2.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 10.9 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 1.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 1.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 1.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 2.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 3.1 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.1 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.4 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 6.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 2.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 2.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 5.0 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 3.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 3.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 1.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 4.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 3.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.9 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.5 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 1.7 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 5.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 4.3 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 1.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.5 | GO:0006183 | GMP biosynthetic process(GO:0006177) GTP biosynthetic process(GO:0006183) |
0.1 | 1.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 2.9 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.1 | 2.6 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.1 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 2.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 2.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 2.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 1.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 1.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 2.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 1.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 5.5 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 4.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 11.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 3.3 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.5 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) quinolinate biosynthetic process(GO:0019805) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.1 | 1.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.7 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.7 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.9 | GO:0015844 | monoamine transport(GO:0015844) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 8.5 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 1.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 2.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.5 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 2.1 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 0.1 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.0 | 3.4 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 2.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.8 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 3.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 2.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 1.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.0 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 1.0 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 3.5 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
0.0 | 2.0 | GO:0048167 | regulation of synaptic plasticity(GO:0048167) |
0.0 | 1.1 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 1.0 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 3.0 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 1.2 | GO:0015758 | glucose transport(GO:0015758) |
0.0 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.7 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 2.6 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.5 | GO:0008542 | visual behavior(GO:0007632) visual learning(GO:0008542) |
0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.6 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.0 | 1.3 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.9 | GO:0030518 | intracellular steroid hormone receptor signaling pathway(GO:0030518) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.8 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.2 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.1 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.5 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.0 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.8 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
3.1 | 27.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
2.0 | 8.1 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
2.0 | 15.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.0 | 7.8 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
1.9 | 7.5 | GO:0044307 | dendritic branch(GO:0044307) |
1.6 | 1.6 | GO:1902737 | dendritic filopodium(GO:1902737) |
1.4 | 28.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.4 | 14.1 | GO:0045298 | tubulin complex(GO:0045298) |
1.3 | 4.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.3 | 8.0 | GO:0043198 | dendritic shaft(GO:0043198) |
1.1 | 3.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.1 | 16.0 | GO:0016342 | catenin complex(GO:0016342) |
1.1 | 16.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 23.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.0 | 3.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.9 | 7.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 2.5 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.8 | 3.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.8 | 3.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 3.0 | GO:0042575 | zeta DNA polymerase complex(GO:0016035) DNA polymerase complex(GO:0042575) |
0.8 | 6.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.8 | 2.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 4.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.7 | 2.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.6 | 22.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.6 | 5.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 5.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 6.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 6.5 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 5.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 12.9 | GO:0031430 | M band(GO:0031430) |
0.6 | 5.0 | GO:0002177 | manchette(GO:0002177) |
0.5 | 3.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 3.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 1.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.5 | 4.2 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 3.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 8.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 3.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.5 | 1.5 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.5 | 13.5 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 3.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 2.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 5.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 4.7 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.3 | GO:1990047 | spindle matrix(GO:1990047) |
0.4 | 3.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 6.4 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 4.7 | GO:0045177 | apical part of cell(GO:0045177) |
0.4 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 4.1 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 5.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 20.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 3.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 5.7 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.3 | 14.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 2.4 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 8.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 6.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 4.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 5.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 1.0 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.3 | 2.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.3 | 6.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 5.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.3 | 18.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.3 | 7.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 3.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 3.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 2.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 2.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 6.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 2.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 3.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 7.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.2 | 9.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 1.5 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.9 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 4.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 10.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 11.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 23.3 | GO:0045202 | synapse(GO:0045202) |
0.2 | 17.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 0.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 9.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 7.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.9 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.0 | GO:0001652 | granular component(GO:0001652) |
0.2 | 7.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 12.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 1.5 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 11.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 2.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 3.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 2.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 2.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 2.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 39.8 | GO:0014069 | postsynaptic density(GO:0014069) |
0.2 | 1.9 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 13.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 11.5 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 2.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 1.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 6.7 | GO:0005929 | cilium(GO:0005929) |
0.2 | 0.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 10.5 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 1.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 9.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 3.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 3.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 4.8 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 42.9 | GO:0030424 | axon(GO:0030424) |
0.1 | 12.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 3.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 1.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 2.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 5.0 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 3.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 4.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 3.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 8.3 | GO:0016605 | PML body(GO:0016605) |
0.1 | 4.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 6.9 | GO:0034702 | ion channel complex(GO:0034702) |
0.1 | 0.7 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 4.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 2.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 9.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 4.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 5.0 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.2 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
0.1 | 0.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 3.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.5 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 7.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 2.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 3.4 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 2.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 2.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 5.0 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.8 | GO:0099568 | cell cortex(GO:0005938) cytoplasmic region(GO:0099568) |
0.0 | 0.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.6 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 3.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 1.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 2.7 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 2.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 3.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 5.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 4.2 | GO:0005874 | microtubule(GO:0005874) supramolecular fiber(GO:0099512) polymeric cytoskeletal fiber(GO:0099513) |
0.0 | 8.5 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.2 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 46.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 7.9 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 15.7 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 8.2 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 31.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.8 | 11.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
3.1 | 12.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
2.8 | 19.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
2.4 | 9.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.3 | 9.0 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
2.2 | 15.7 | GO:0099609 | microtubule lateral binding(GO:0099609) |
2.2 | 8.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.0 | 6.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.9 | 7.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.7 | 6.8 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
1.7 | 8.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
1.6 | 14.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.6 | 14.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.5 | 10.7 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.5 | 7.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.5 | 8.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.4 | 4.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.3 | 11.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.3 | 5.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
1.2 | 6.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 5.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
1.2 | 8.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.0 | 3.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.0 | 6.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.0 | 6.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 4.1 | GO:0038025 | reelin receptor activity(GO:0038025) |
1.0 | 7.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.0 | 6.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.0 | 3.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.0 | 7.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 2.9 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.0 | 3.9 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.9 | 5.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 9.4 | GO:0031005 | filamin binding(GO:0031005) |
0.9 | 0.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.9 | 8.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.9 | 3.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 2.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.9 | 7.1 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 3.5 | GO:0035851 | histone deacetylase activity (H4-K16 specific)(GO:0034739) Krueppel-associated box domain binding(GO:0035851) |
0.9 | 3.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.8 | 2.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.8 | 2.5 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.8 | 11.2 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 4.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.8 | 45.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.8 | 8.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.8 | 2.3 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.8 | 2.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.8 | 3.8 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.8 | 24.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 1.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.7 | 11.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 6.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.7 | 17.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 16.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.7 | 4.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.1 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
0.7 | 2.1 | GO:0004534 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) 5'-3' exoribonuclease activity(GO:0004534) |
0.7 | 2.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.7 | 9.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 1.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.6 | 1.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.6 | 1.9 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 12.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.6 | 3.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 3.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 5.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 1.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.6 | 3.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 5.1 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 2.2 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.6 | 7.8 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 2.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 1.7 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 1.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.5 | 4.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.5 | 3.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 1.6 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.5 | 2.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 7.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 3.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.5 | 1.5 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.5 | 6.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 1.5 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.5 | 1.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.5 | 15.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 3.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 6.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 1.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.5 | 1.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 3.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.5 | 1.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.5 | 5.2 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 7.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 1.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.5 | 5.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 2.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 8.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 2.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 2.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 5.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 4.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 23.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 2.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.4 | 11.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 26.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 5.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 4.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 2.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 3.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 1.6 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.4 | 19.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.4 | 1.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 14.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 3.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 2.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 3.7 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.4 | 8.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 2.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 1.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 8.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 3.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 5.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 72.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.3 | 6.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 20.0 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 4.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 5.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 2.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 0.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 5.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 3.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 5.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 6.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.3 | 5.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 1.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 0.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.3 | 10.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 4.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 2.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 3.0 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 8.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 3.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.2 | 1.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 2.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.9 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.2 | 6.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.7 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.2 | 3.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 2.3 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.2 | 6.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 3.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 7.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 2.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 5.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.5 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 2.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 85.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 8.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 2.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 5.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 4.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 9.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 2.3 | GO:0031078 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 5.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 11.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 3.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 2.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.1 | 7.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 3.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 30.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 2.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 5.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 2.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 8.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 6.9 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 2.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 6.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 5.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 3.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 2.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 2.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 2.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 6.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 2.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 8.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 2.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.7 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 1.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 2.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 1.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 4.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 2.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 2.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 2.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 4.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 4.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 5.6 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.7 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 2.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.9 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 2.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 1.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 4.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 25.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 4.1 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.1 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 2.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 1.6 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.4 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.6 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.3 | GO:0008009 | chemokine activity(GO:0008009) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 48.8 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.8 | 15.6 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 46.8 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.6 | 7.2 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.6 | 25.3 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
0.5 | 15.8 | PID_IL3_PATHWAY | IL3-mediated signaling events |
0.5 | 3.7 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 7.8 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 20.9 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 2.9 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.4 | 24.5 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.3 | 15.5 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.3 | 2.3 | ST_GA12_PATHWAY | G alpha 12 Pathway |
0.3 | 16.5 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
0.3 | 2.5 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 12.5 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
0.2 | 11.1 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 5.6 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.6 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.2 | 7.1 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
0.2 | 3.7 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 5.0 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 7.9 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.2 | 1.7 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.2 | 3.1 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 6.4 | PID_FOXO_PATHWAY | FoxO family signaling |
0.2 | 8.0 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 6.1 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
0.2 | 7.3 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.3 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.2 | 7.1 | PID_TCR_PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 2.4 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 4.1 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 4.4 | PID_SHP2_PATHWAY | SHP2 signaling |
0.2 | 4.0 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 8.5 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
0.2 | 3.3 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 6.9 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.4 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 5.2 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.8 | PID_INSULIN_PATHWAY | Insulin Pathway |
0.1 | 2.6 | PID_IFNG_PATHWAY | IFN-gamma pathway |
0.1 | 1.8 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.1 | 3.5 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 6.4 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.1 | 6.6 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.9 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.1 | 3.1 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.7 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.6 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.1 | 6.3 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 12.4 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.4 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.8 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.1 | 1.4 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.1 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.4 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.8 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.1 | 0.8 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.1 | 1.3 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.7 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.0 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.0 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.7 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | PID_ARF_3PATHWAY | Arf1 pathway |
0.0 | 0.3 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 4.5 | REACTOME_CELL_CELL_COMMUNICATION | Genes involved in Cell-Cell communication |
1.6 | 19.7 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
1.0 | 3.1 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.9 | 17.3 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.8 | 16.0 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.8 | 28.2 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 1.5 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
0.7 | 15.6 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 7.2 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 6.9 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 7.9 | REACTOME_INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 12.1 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 38.7 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 11.7 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 3.8 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 3.2 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 19.0 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 3.1 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 2.5 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 8.5 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 14.9 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 4.8 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 9.5 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 15.0 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 10.3 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 5.4 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.3 | 5.2 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 7.0 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.3 | 4.0 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 4.2 | REACTOME_IL_3_5_AND_GM_CSF_SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 26.4 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 5.4 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 11.8 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 9.2 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 3.0 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 3.9 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 10.3 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 2.6 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 4.6 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 4.3 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
0.3 | 4.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 8.2 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.3 | 10.1 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 7.4 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.2 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.6 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 7.9 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 15.0 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 3.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 2.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.3 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.2 | 2.3 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.8 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.5 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 4.3 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.2 | 4.2 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 12.5 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 5.7 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.7 | REACTOME_PI_METABOLISM | Genes involved in PI Metabolism |
0.2 | 2.6 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.7 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.4 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.7 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 8.2 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.5 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.1 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.9 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.2 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.7 | REACTOME_RNA_POL_III_TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 1.4 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 3.8 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.0 | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.6 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.7 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.7 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 4.7 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.3 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.1 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.4 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 6.1 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.8 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.6 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 5.5 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.4 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 5.4 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.5 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.5 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 6.9 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.3 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.3 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 2.6 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |